N.E.W. Advisory Services’s NovoCure NVCR Stock Holding History

N.E.W. Advisory Services’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.09K	Hold	600	–	–	﹤0.01%	664
2026 Q1	$6.54K	Hold	600	–	–	﹤0.01%	698
2025 Q4	$7.76K	Hold	600	–	–	﹤0.01%	655
2025 Q3	$7.75K	Hold	600	–	–	﹤0.01%	610
2025 Q2	$10.7K	Hold	600	–	–	﹤0.01%	555
2025 Q1	$10.7K	Buy	+600	New	+$13.6K	﹤0.01%	600

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

N.E.W. Advisory Services's NVCR Position: Q2 2026 in Review

N.E.W. Advisory Services held its NovoCure (NVCR) position steady in Q2 2026 at 600 shares worth $9.09K. The position accounts for ﹤0.01% of the portfolio, ranked #664.

N.E.W. Advisory Services first reported a position in NVCR in Q1 2025 and has held it in 6 quarters since. The position peaked at $10.7K in Q1 2025. 216 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

N.E.W. Advisory Services held 600 shares of NovoCure worth $9.09K as of Q2 2026.
N.E.W. Advisory Services left its NovoCure share count unchanged in Q2 2026.
NovoCure made up ﹤0.01% of N.E.W. Advisory Services's portfolio in Q2 2026, its #664 holding.
N.E.W. Advisory Services first reported a position in NovoCure in Q1 2025 and has held it in 6 quarters since.
N.E.W. Advisory Services's NovoCure position peaked at $10.7K in Q1 2025.
216 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on N.E.W. Advisory Services's 13F filing for Q2 2026, filed 6 Aug 2026.